REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Nitrogen Containing Other Than Solely As A Nitrogen In An Inorganic Ion Of An Addition Salt, A Nitro Or A Nitroso Doai > R Contains Benzene Ring > Plural Carboxamide Groups Or Plural C=o Groups Bonded Directly To The Same Nitrogen Plural Carboxamide Groups Or Plural C=o Groups Bonded Directly To The Same NitrogenPlural Carboxamide Groups Or Plural C=o Groups Bonded Directly To The Same Nitrogen patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/18/07 - 20070015835 - Active substance combinations having insecticidal and acaricidal properties The present invention relates to novel insecticidally and acaricidally active compound combinations of N2-[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide of the formula (I) and the active compounds identified in the disclosure. ... 08/24/06 - 20060189697 - Crystalline acat inhibitor The invention is directed to the Form A polymorph of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide and its use as a therapeutic/cosmetic agent. ... 08/24/06 - 20060189696 - Polyamine conjugates with acidic retinoids and preparation thereof Invented are novel polyamine conjugates which have been readily obtained using as key-step the condensation of linear, conformationally restricted, cyclic and branched polyamides or suitably protected derivatives with vitamin A derivatives. These compounds inhibit the ribozyme rivbonuclease P (RNase P) and the production of interleukin-2 (IL-2) amd interferon-γ (INF-γ) by ... 07/13/06 - 20060154989 - Trimeric, macrocyclically substituted halo-benzene derivatives in which Hal stands for bromine or iodine, and A1 and A2 have different meanings, are suitable as contrast media. ... 06/22/06 - 20060135619 - Anthranilic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase 3 Anthranilic acid drivatives, methods of using such compounds in the treatment of hormone sensitive diseases such as prostate cancer, and pharmaceutical compositions containing such compounds. ... 06/08/06 - 20060122279 - Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants wherein X is O or H, H; R is a hydrophobic C12-C20 chain and Y is -NH2 or -H; and pharmaceutically acceptable salts thereof and prodrugs thereof. ... 04/20/06 - 20060084703 - Injectable liquid formulation of paracetamol The invention relates to a novel injectable liquid formulation of paracetamol, comprising an aqueous solvent, a buffer agent with a pKa between 4.5 and 6.5, an isotonic agent and the dimer of paracetamol of formula (I), a method for preparation of said formulation and the use of said dimer for ... 02/23/06 - 20060041024 - Polycationic compounds and uses thereof Aspects of the present invention relate to compounds and methods useful in modulating angiogenesis and methods of treating or preventing diseases associated with angiogenesis by administering a polycationic compound. The present invention relates to methods of use and compositions for inhibiting angiogenesis-mediated disorders in mammals including animals and humans. Additionally, ... 02/23/06 - 20060041023 - Facially amphilic polymers and oligomers and uses thereof The present invention discloses methods of use of facially amphiphilic polymers and oligomers, including pharmaceutical uses of the polymers and oligomers as antimicrobial agents and antidotes for hemorrhagic complications associated with heparin therapy. The present invention also discloses novel facially amphiphilic polymers and oligomers and their compositions, including pharmaceutical compositions. ... 02/02/06 - 20060025485 - Hydroxybenazamide compounds for treatment of cancer The present invention provides for the treatment of cancers, particularly neuroendocrine cancers, using the Raf-1 inducer ZM336372, or analogs thereof. ... 11/03/05 - 20050245615 - Composition containing polyamine transport inhibitor and use thereof X is —CO—, —SO2—, or —CH2—; and L is a covalent bond or a naturally occurring amino acid, lysine, ornithine, 2,4-diaminobutyric acid, or pharmaceutically acceptable salts thereof or prodrug thereof, and a polyamine biosynthesis inhibitor. ... 09/08/05 - 20050197403 - Dimeric small molecule potentiators of apoptosis Caspase activity and apoptosis are promoted using active, dimeric Smac peptide mimetics of the general formula M1-M2, wherein moieties M1 and M2 are monomeric Smac mimetics and L is a covalent linker. Target cancerous or inflammatory cells are contacted with an effective amount of an active, dimeric Smac mimetic, and ... 08/18/05 - 20050182138 - Dipeptide inhibitors of beta-secretase Dipeptide derived inhibitors of the β-secretase enzyme are provided which are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of Aβ peptide in a mammal. The compounds of the invention provide useful methods of treatment by administration of these inhibitors to reduce Aβ peptide formation ... 07/28/05 - 20050165114 - Benzene derivatives and pharmaceutical use thereof The present invention provides an AP-1 activation inhibitor, NF-kappa B activation inhibitor, inflammatory cytokine production inhibitor, matrix metalloprotease production inhibitor, inflammatory cell adhesion molecule expression inhibitor, anti-inflammatory agent, antirheumatic agent, immunosuppressant, cancer metastasis inhibitor, remedy for arteriosclerosis and antiviral agent which contain the benzene derivative of the following general formula ... 06/16/05 - 20050131069 - Derivatives and pharmaceutical compositions of n-hydroxyalkyl tetramethylcyclopropane-carboxamide, having anti-epiletic, neurological, and cns activity, and method for their preparation New derivatives of N-Hydroxyalkyl-tetramethylcyclopropane carboxamide, pharmaceutical compositions thereof, methods for their preparation, and use thereof for the treatment of epilepsy, neurological, affective and psychotic disorders and for the treatment of pain and migraine. ... ### FreshPatents.com Support |